Influence of the C242T polymorphism of the p22-phox gene (CYBA) on the interaction between urinary sodium excretion and blood pressure in an urban Brazilian population

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Schreiber, Roberto ^a   Bellinazzi, Vera Regina ^a   Sposito, Andrei C ^a   Mill, José G ^b   Krieger, José E ^c   Pereira, Alexandre C ^c   Nadruz Jr , Wilson ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYTOCHROME B; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POTASSIUM; SODIUM; TRIACYLGLYCEROL; URIC ACID; CYBA PROTEIN, HUMAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ADULT; AFRICAN AMERICAN; AGE; ALLELE; ANTHROPOMETRY; ARTICLE; BODY MASS; BRAZIL; CAUCASIAN; CONFOUNDING VARIABLE; CORRELATION ANALYSIS; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERTENSION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; RACE DIFFERENCE; REGRESSION ANALYSIS; SMOKING; SODIUM EXCRETION; SODIUM INTAKE; SYSTOLIC BLOOD PRESSURE; URBAN AREA; URINARY EXCRETION; BLOOD PRESSURE; GENETICS; PATHOPHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICS AND NUMERICAL DATA; URBAN POPULATION; URINE;

ADULT; BLOOD PRESSURE; BRAZIL; FEMALE; GENOTYPE; HUMANS; HYPERTENSION; MALE; NADPH OXIDASE; POLYMORPHISM, SINGLE NUCLEOTIDE; SODIUM; URBAN POPULATION;

EID: 84891954874     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081054     Document Type: Article

References (29)

1. Tian N, Thrasher KD, Gundy PD, Hughson MD, Manning RD Jr (2005) Antioxidant treatment prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension. Hypertension 45:934-939. (Pubitemid 40628940)
2. Banday AA, Muhammad AB, Fazili FR, Lokhandwala M (2007) Mechanisms of oxidative stress-induced increase in salt sensitivity and development of hypertension in Sprague-Dawley rats. Hypertension 49:664-671.
3. Cave AC, Brewer AC, Narayanapanicker A, Ray R, Grieve DJ, et al. (2006) NADPH oxidases in cardiovascular health and disease. Antioxid. Redox Signal 8:691-728. (Pubitemid 44043102)
4. Ambasta RK, Kumar P, Griendling KK, Schmidt HH, Busse R, et al. (2004) Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J Biol Chem 279:45935-45941. (Pubitemid 39491586)
5. Zalba G, San José G, Moreno MU, Fortunõ A, Díez J (2005) NADPH oxidasemediated oxidative stress: genetic studies of the p22 (phox) gene in hypertension. Antioxid Redox Signal 7:1327-1336. (Pubitemid 41232530)
6. San José G, Fortunõ A, Beloqui O, Díez J, Zalba G (2008) NADPH oxidase CYBA polymorphisms, oxidative stress and cardiovascular diseases. Clin Sci 114:173-182. (Pubitemid 351293993)
7. Shimo-Nakanishi Y, Hasebe T, Suzuki A, Mochizuki H, Nomiyama T, et al. (2004) Functional effects of NAD (P) H oxidase p22 (phox) C242T mutation in human leukocytes and association with thrombotic cerebral infarction. Atherosclerosis 175:109-115. (Pubitemid 38746917)
8. Wu Z, Lou Y, Jin W, Liu Y, Lu L, et al. (2013) Relationship of the p22phox (CYBA) Gene Polymorphism C242T with Risk of Coronary Artery Disease: A Meta-Analysis. PLoS One 8:e70885.
9. Li BH, Zhang LL, Zhang BB, Yin YW, Dai LM, et al. (2013) Association between NADPH oxidase p22 (phox) C242T polymorphism and ischemic cerebrovascular disease: a meta-analysis. PLoS One 8:e56478.
10. Schreiber R, Ferreira-Sae MC, Tucunduva AC, Mill JG, Costa FO, et al. (2012) CYBA C242T polymorphism is associated with obesity and diabetes mellitus in Brazilian hypertensive patients. Diabet Med 29:e55-e61.
11. Schreiber R, Ferreira-Sae MC, Ronchi JA, Pio-Magalhães JA, Cipolli JA, et al. (2011) The C242T polymorphism of the p22-phox gene (CYBA) is associated with higher left ventricular mass in Brazilian hypertensive patients. BMC Med Genet 12:114.
12. Arcand J, Floras JS, Azevedo E, Mak S, Newton GE, et al. (2011) Evaluation of 2 methods for sodium intake assessment in cardiac patients with and without heart failure: the confounding effect of loop diuretics. Am J Clin Nutr 93:535-541.
13. Pereira AC, Mota GA, Bensenõr I, Lotufo PA, Krieger JE (2001) Effect of race, genetic population structure, and genetic models in two-locus association studies: clustering of functional renin-angiotensin system gene variants in hypertension association studies. Braz J Med Biol Res 34:1421-1428. (Pubitemid 34036844)
14. Schreiber R, Mill JG, Krieger JE, Pereira AC, Nadruz W Jr (2013) Association between glutathione S-transferase M1 polymorphism and urinary sodium excretion in a Brazilian population. Am J Hypertens 26:1024-1029.
15. Kuznetsova T, Staessen JA, Brand E, Cwynar M, Stolarz K, et al. (2006) European Project on Genes in Hypertension Investigators. Sodium excretion as a modulator of genetic associations with cardiovascular phenotypes in the European Project on Genes in Hypertension. J Hypertens 24:235-242. (Pubitemid 43348228)
16. Sanada H, Jones JE, Jose PA (2011) Genetics of salt-sensitive hypertension. Curr Hypertens Rep 13:55-66.
17. Bochud M, Eap CB, Elston RC, Bovet P, Maillard M, et al. (2006) Association of CYP3A5 genotypes with blood pressure and renal function in African families. J Hypertens 24:923-929. (Pubitemid 43670464)
18. Castejon AM, Bracero J, Hoffmann IS, Alfieri AB, Cubeddu LX (2006) NAD (P) H oxidase p22phox gene C242T polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics. J Hum Hypertens 20:772-779. (Pubitemid 44430676)
19. WHO MONICA Project Principal Investigators (1988) The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol 41:105-114.
20. Executive Summary: The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation And Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2001) JAMA 285:2486-2497.
21. Mill JG, da Silva AB, Baldo MP, Molina MC, Rodrigues SL (2012) Correlation between sodium and potassium excretion in 24- and 12-h urine samples. Braz J Med Biol Res 45:799-805.
22. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
23. Cahilly C, Ballantyne CM, Lim DS, Gotto A, Marian AJ (2000) A variant of p22 (phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis. Circ Res 86:391-395. (Pubitemid 30141757)
24. Ito D, Murata M, Watanabe K, Yoshida T, Saito I, et al. (2000) C242T polymorphism of NADPH oxidase p22 PHOX gene and ischemic cerebrovascular disease in the Japanese population. Stroke 31:936-939. (Pubitemid 30198442)
25. Kim KI, Na JE, Kang SY, Cho YS, Choi DJ, et al. (2007) Impact of NAD (P) H oxidase p22 phox gene polymorphism on vascular aging in Korean centenarian and nonagenarian. Int J Cardiol 123:18-22. (Pubitemid 350116974)
26. Toda N, Arakawa K (2011) Salt-induced hemodynamic regulation mediated by nitric oxide. J Hypertens. 29:415-424.
27. Gill PS, Wilcox CS (2006) NADPH oxidases in the kidney. Antioxid Redox Signal. 8:1597-607. (Pubitemid 44726334)
28. Yokoyama M, Inoue N, Kawashima S (2000) Role of the vascular NADH/NADPH oxidase system in atherosclerosis. Ann N Y Acad Sci. 902:241-247.
29. Bisi Molina Mdel C, Cunha Rde S, Herkenhoff LF, Mill JG (2003) Hypertension and salt intake in an urban population. Rev Saúde Pública 37:743-750. (Pubitemid 38088160)